Simplifying Global Compliance
FDAnews Drug Daily Bulletin
First Trial of Vaccine to Treat Parkinson’s Disease Begins
The Austrian company AFFiRiS A.G. of Vienna said this week it has begun the first-ever clinical trials of a vaccine to treat Parkinson’s disease. The study of as many as 32 patients is designed to test the safety and tolerability of the vaccine, called PD01A.
Los Angeles Times
Copyright ©2015. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing